Vlad Popovici

Has grant

associate professor

Masaryk University

Czech Republic

Research Interests

Explore related searches

Professors in Microbiology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Vlad Popovici is an associate professor at Masaryk University in the Czech Republic. His research primarily focuses on colorectal cancer, investigating the morphological heterogeneity and microbiome influences in tumor progression. Recent articles highlight his work in analyzing tumor mutations, therapeutic responses, and the development of regulatory network reconstruction using multi-omics data.

Recent Grants

Grant: Close

Clinical implications of intra-tumour heterogeneity in colon cancer

Open Date: 2019-01-05

Close Date: 2022-12-31

Grant: Close

Molecular portraits of major morphological components of colon tumors

Open Date: 2019-01-01

Close Date: 2022-12-31

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Collaborators (5)

Simon Schallenberg

GERMANY

View details

Jan Stenvang

Associate Professor

University of Copenhagen

DENMARK

View details

Eva Budinska

Assistant professor, group leader

Masaryk University

CZECH REPUBLIC

View details

Fred Bosman

Emeritus professor

University of Lausanne

SWITZERLAND

View details

Rudolf Nenutil

Masaryk Memorial Cancer Institute

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vlad Popovici

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (11)

A quantitative tumor‐wide analysis of morphological heterogeneity of colorectal adenocarcinoma

Search for Mutations Connected With Non-Response to Anti-EGFR Therapy in mCRC in the Morphologically Defined Regions of Primary Tumours.

A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC).

Impact of the ONCOBIOME network in cancer microbiome research.

A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers.

An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancer.

Molecular portraits of colorectal cancer morphological regions

IntOMICS: A Bayesian Framework for Reconstructing Regulatory Networks Using Multi-Omics Data

Using empirical biological knowledge to infer regulatory networks from multi-omics data

Colorectal tumour mucosa microbiome is enriched in oral pathogens and defines three subtypes that correlate with markers of tumour progression

An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial

Collaborators (5)

Simon Schallenberg

Jan Stenvang

Eva Budinska

Fred Bosman

Rudolf Nenutil

Make your next move.